Newsroom
Sorted by: Latest
-
BostonGene to Present AI Innovations at BIO 2026
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, leading developer of AI models for tumor and immune biology, today announced its participation at The BIO International Convention (BIO 2026), the largest and most comprehensive event for biotechnology. Representing the full ecosystem of biotech, the convention brings together 20,000 industry leaders from around the world from June 22 – 25 at the San Diego Convention Center in San Diego, California. Presentation details: Title: Clinical Trial Advanta...
-
Imperial renews annual normal course issuer bid
CALGARY, Alberta--(BUSINESS WIRE)--Imperial renews annual normal course issuer bid...
-
L’Impériale renouvelle l’offre publique de rachat dans le cours normal des activités
CALGARY, Alberta--(BUSINESS WIRE)--La Compagnie Pétrolière Impériale Limitée (TSE : IMO, NYSE American : IMO) a annoncé aujourd’hui qu’elle avait obtenu le consentement définitif de la Bourse de Toronto (« TSX ») relativement à une offre publique de rachat dans le cours normal des activités (« offre publique de rachat »), en vue de racheter jusqu’à 5 % de ses 483 592 715 actions ordinaires en circulation en date du 15 juin 2026, soit un maximum de 24 179 635 actions, au cours des 12 prochains m...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 22.06.2026 FTAI IE000YIQZ0H6 200,002.00 USD 6,245,390.94 31.227 ...
-
European Commission Approves Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted marketing authorization for Trodelvy® (sacituzumab govitecan-hziy) as monotherapy for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy for metastatic disease and are not candidates for PD-1 or PD-L1 inhibitor therapy. Trodelvy is the first antibody-drug conjugate (...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 22.06.2026 MJUN LN IE000CO3P697 150,002.00 USD 3,799,052.24 25.327 ...
-
75% of Financial Institutions Enter Receivables Modernization Window
NEW YORK--(BUSINESS WIRE)--New Datos Insights research for CheckAlt finds 75% of banks/credit unions are entering an 18-month receivables modernization window....
-
Dare County School Board Unanimously Approves New On-Site After School Provider at All Five Elementary Schools
NAGS HEAD, N.C.--(BUSINESS WIRE)--Working parents across the Outer Banks will soon have expanded access to after-school care. At its June 8 meeting, the Dare County Board of Education voted unanimously to partner with Right At School—the nation’s fastest-growing provider of on-site, school-based after school enrichment—to operate programs in all five district elementary schools beginning this fall. The partnership will reduce waitlists while expanding access to care on early release days, non-i...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 22.06.2026 QDEC.LN IE000GAKWFA7 600,002.00 USD 14,593,373.78 24.322 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 22.06.2026 FKUD IE00BD9N0445 121,463.00 GBP 3,670,878.60 30.222 ...